Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parissa Tabrizian

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2019
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decadesMarc Puigvehí, Dana Hashim, Philipp K Haber, et al.
Annals of Surgical Oncology|December 16, 2025
Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic CancerJudy Li, Thomas M Li, Adam Geffner, et al.
Annals of Surgical Oncology|February 23, 2026
ASO Visual Abstract: Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic CancerJudy Li, Thomas M Li, Adam Geffner, et al.
Annals of Surgical Oncology|February 9, 2024
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International AnalysisMatthew L Holzner, Vincenzo Mazzaferro, Michele Droz Dit Busset, et al.
Clinical Transplantation|November 25, 2025
Initial Efforts to Stratify Patients and Donors Utilizing Normothermic Machine Preservation of Livers for TransplantKimberly M Feeney, Leonie van Leeuwen, Rachel Todd, et al.
Oncogene|October 24, 2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinomaJohann von Felden, Amanda J Craig, Teresa Garcia-Lezana, et al.
Hepatology (Baltimore, Md.)|February 26, 2026
The rise of transplant oncology in primary liver cancer and metastatic diseaseCharles-Henri Wassmer, Maximiliano Gelli, Tiffany Cho Lam Wong, et al.
International Journal of Surgery (London, England)|February 5, 2025
Predicting futile outcomes following deceased donor liver transplantation in non-HCC patients with MELD-Na score above 30: a retrospective international multicenter cohort studyHye-Sung Jo, Young-In Yoon, Ki-Hun Kim, et al.
Transplantation|December 14, 2021
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus ConferenceJordi Colmenero, Parissa Tabrizian, Prashant Bhangui, et al.
Immunity|December 15, 2022
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH developmentXiaochen Wang, Qifeng He, Chuanli Zhou, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2019
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decadesMarc Puigvehí, Dana Hashim, Philipp K Haber, et al.
Annals of Surgical Oncology|December 16, 2025
Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic CancerJudy Li, Thomas M Li, Adam Geffner, et al.
Annals of Surgical Oncology|February 23, 2026
ASO Visual Abstract: Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic CancerJudy Li, Thomas M Li, Adam Geffner, et al.
Annals of Surgical Oncology|February 9, 2024
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International AnalysisMatthew L Holzner, Vincenzo Mazzaferro, Michele Droz Dit Busset, et al.
Clinical Transplantation|November 25, 2025
Initial Efforts to Stratify Patients and Donors Utilizing Normothermic Machine Preservation of Livers for TransplantKimberly M Feeney, Leonie van Leeuwen, Rachel Todd, et al.
Oncogene|October 24, 2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinomaJohann von Felden, Amanda J Craig, Teresa Garcia-Lezana, et al.
Hepatology (Baltimore, Md.)|February 26, 2026
The rise of transplant oncology in primary liver cancer and metastatic diseaseCharles-Henri Wassmer, Maximiliano Gelli, Tiffany Cho Lam Wong, et al.
International Journal of Surgery (London, England)|February 5, 2025
Predicting futile outcomes following deceased donor liver transplantation in non-HCC patients with MELD-Na score above 30: a retrospective international multicenter cohort studyHye-Sung Jo, Young-In Yoon, Ki-Hun Kim, et al.
Transplantation|December 14, 2021
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus ConferenceJordi Colmenero, Parissa Tabrizian, Prashant Bhangui, et al.
Immunity|December 15, 2022
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH developmentXiaochen Wang, Qifeng He, Chuanli Zhou, et al.
Pageof 14